Discover educational insights on blistering diseases and innovative treatments like dupilumab at the Maui Derm NP+PA Fall 2025 conference.
Expert Interviews
Kara Mudd, PA-C, shares vital insights on atopic dermatitis, rosacea, and contact dermatitis from Maui Derm NP+PA Fall 2025, enhancing clinical practice.
Walter Liszewski, MD, shares innovative and personalized treatment strategies for managing atopic and contact dermatitis at Maui Derm NP+PA Fall 2025.
Discover key insights from Maui Derm NP+PA Fall 2025 on acne and rosacea treatments, featuring expert strategies from Hilary Baldwin, MD.
Discover the latest advancements in pediatric dermatology and atopic dermatitis treatments from Maui Derm NP+PA Fall 2025, featuring expert insights and emerging therapies.
Stephanie Simmerman, DNP, APRN-C, led discussions on psoriasis treatment innovations at Maui Derm NP+PA Fall 2025, highlighting NP and PA advancements.
George Martin, MD, reveals cutting-edge treatments for vitiligo, psoriasis, and psoriatic arthritis at Maui Derm NP+PA Fall 2025, enhancing patient care strategies.
Discover expert insights on treating uncommon conditions like lichen planus, CSU, and polymorphous light eruption from Maui Derm NP+PA Fall 2025.
Panelists discuss how atopic dermatitis exhibits tremendous heterogeneity in clinical presentation, disease course, symptom variability, environmental triggers, and underlying immunologic and genetic factors that contribute to the challenge of developing one-size-fits-all treatments.
A panelist discusses a case of moderate seborrheic dermatitis in a 34-year-old African American woman, emphasizing the need for individualized, culturally sensitive treatment plans that accommodate hair type and styling preferences, illustrating how an intermittent ketoconazole shampoo regimen aligned with her routine led to symptom improvement.
Panelists discuss how despite recent therapeutic advances in atopic dermatitis treatment, significant unmet needs remain including partial responses, lack of long-term stable control, and the need for broader patient response rates and deeper clearance levels.
Discover expert insights on cutaneous oncology from George Martin, MD, focusing on innovative treatments for skin cancers at Maui Derm NP+PA Fall.
Discover key insights from the Maui Derm NP+PA Fall 2025 Conference on advances in dermatology, including new treatments and research findings.
Discover groundbreaking dermatologic therapies and new drug approvals presented at Maui Derm NP+PA Fall, featuring insights from experts George Martin, MD, and Ted Rosen, MD.
Elena Hawryluk, MD, PhD, highlights innovative pediatric dermatology at Maui Derm NP+PA Fall, emphasizing education and advancements in tumor genetics.
Preview the Maui Derm NP+PA Fall 2025 Conference with program director George Martin, MD, featuring cutting-edge education and expert insights in Nashville.
Evidence presented at EADV supports upadacitinib’s long-term use in atopic dermatitis and other inflammatory conditions.
Galvokamig, a biologic targeting IL-13 and IL-17A/F, demonstrated significant benefits in moderate to severe atopic dermatitis.
Panelists discuss the importance of a gentle, minimalist skin care routine tailored to support the skin barrier in sensitive or compromised skin, emphasizing the use of pH-balanced cleansers, barrier-repairing moisturizers, and condition-specific strategies to reduce irritation and promote long-term skin health.
transepidermal water loss as a key indicator of skin barrier integrity, highlighting its relevance in both clinically diagnosed and self-perceived sensitive skin, and emphasizing the importance of barrier-supportive skin care to reduce water loss, promote repair, and manage sensitivity effectively.
Nicole Harter, MD, explores ruxolitinib 1.5% cream for pediatric atopic dermatitis, offering a novel, effective treatment option for children aged 2 to 11.
Nayan Patel, PharmD, reveals how innovative glutathione delivery transforms skin care, combats oxidative stress, and empowers skin health for lasting results.
Discover how Auro GSH by Nayan Patel, PharmD, revolutionizes glutathione delivery in skin care, targeting oxidative stress for healthier skin.
A panelist presents a case of severe, chronic facial seborrheic dermatitis in a young man, highlighting diagnostic challenges and emotional impact, and illustrating how daily use of a phosphodiesterase-4 (PDE4) inhibitor foam led to near-clearance and symptom relief by 8 weeks, underscoring the therapy’s effectiveness, safety, and adaptability to patient preferences.
Panelists discuss the structure and function of the skin barrier, highlighting key components like filaggrin and aquaporins, and emphasizing the need to protect against both environmental and lifestyle-related stressors—collectively known as the exposome—to maintain hydration and support long-term skin health.
Panelists discuss the critical role of maintaining a healthy skin barrier in managing sensitive skin, emphasizing the importance of gentle, evidence-based cleansing and moisturizing practices to prevent irritation, support barrier repair, and improve dermatologic outcomes.
Discover the benefits of RetaXome therapy for sensitive skin and its potential in skin care routines.
Novel formulations like retinal-infused exosomes represent an evolution rather than a replacement of retinoid therapy.
A panelist presents a case of severe seborrheic dermatitis in a young man with facial and scalp involvement, demonstrating how a once-daily, foam-based phosphodiesterase-4 (PDE4) inhibitor provided rapid, complete clearance and itch relief, highlighting the importance of efficacy, cosmetic acceptability, and quality-of-life considerations in treatment selection.
Sofia Wenzler, PhD, highlights the vital role dermatologists play in treating body-focused repetitive behaviors like skin picking and hair pulling.
